Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05202210

Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome

The present study will establish a collection of biological samples from Noonan patients to be used for research purposes only, with due respect for confidentiality.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Purpan University Hospital

Toulouse, 31059, France

Location status: Recruiting

Location contact

Françoise Auriol, PhD

CONTACT

[email protected]

5 61 77 10 95 ext. 0033

About this study

Noonan syndrome is a rare autosomal dominant genetic disorder characterized by a combination of typical facial features, heart defects, short stature, skeletal abnormalities, mild developmental delay and a predisposition to myeloproliferative disorders. This syndrome is caused by germline mutations in genes encoding components or regulators of the Rat Sarcoma (RAS) / extracellular signal-regulated kinase (ERK) signaling pathway, which is essential for cell cycle differentiation, growth, and senescence.

Patients with Noonan syndrome or related diseases are followed at the children's hospital, Toulouse University Hospital. During regular check-up visits, an extra sample of blood and urine will be collected and stored for research utilisation with the patient's consent. The ultimate objective of this collection is to provide available biological resources to facilitate the development of subsequent studies aimed at better characterizing the multisystemic disorders in Noonan syndrome, to understand the pathophysiology of the disease, and to identify biological factors that predict the severity and progression of the disease. The possibility of having systematically collected biological resources will make it possible to answer certain questions more quickly depending on the progress of research.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children aged at least 3 years old or adult with Noonan syndrome
  • Patients affiliated to or beneficiaries of a social security scheme
  • Patients able to receive information on the progress of the study and understand the information form to participate in the study. That implies to master the French language and not to be subject to a restriction of rights by the judicial authorities
  • Patients or legal representative who have given their consent to participate in the study (expression of no objection)

Exclusion criteria

  • Patients subject to a legal protection measure (guardianship, curators, or safeguard of justice)
  • Pregnant or breastfeeding women

Treatment and study plan

blood and urine sampling

Biological

extra sample of blood and urine will be collected

Primary outcomes

  1. Constitution of a biological collection from patients with Noonan or related syndromes.

    Time frame: inclusion

    extra sample of blood and urine will be collected

Study contacts

Contact information is provided by the study sponsor or research team.

Françoise Auriol, PhD

CONTACT

[email protected]

5 67 77 10 95 ext. 0033

Thomas EDOUARD, MD, PhD

CONTACT

[email protected]

5 34 55 85 55 ext. 0033

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Registry information

Official study title

Constitution of a Biological Collection to Study the Pathophysiology in Noonan Syndrome and to Identify Predictive Factors of Disease Progression

Acronym: Noonan

Important dates

Study start
2022
Primary completion
2027
Study completion
2032
First posted
Jan 21, 2022
Registry last updated
Mar 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.